The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy

Abstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryosuke Takegawa, Kei Hayashida, Atsushi Murao, Yusuke Endo, Cyrus E. Kuschner, Jacob Kazmi, Eriko Nakamura, Ping Wang, Lance B. Becker
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86760-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571763454640128
author Ryosuke Takegawa
Kei Hayashida
Atsushi Murao
Yusuke Endo
Cyrus E. Kuschner
Jacob Kazmi
Eriko Nakamura
Ping Wang
Lance B. Becker
author_facet Ryosuke Takegawa
Kei Hayashida
Atsushi Murao
Yusuke Endo
Cyrus E. Kuschner
Jacob Kazmi
Eriko Nakamura
Ping Wang
Lance B. Becker
author_sort Ryosuke Takegawa
collection DOAJ
description Abstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation protocols. This study aimed to assess a rapid mitochondrial isolation method, examine the relationship between mitochondrial size and membrane potential, and evaluate the potential benefits of Poloxamer 188 (P-188) in improving mitochondrial quality during the isolation process. Mitochondria were isolated from pectoral muscle biopsies of adult male Sprague–Dawley rats using an automated homogenizer. MitoTracker Deep Red (MTDR) staining and flow cytometry were used to assess mitochondrial purity, while the JC-1 assay evaluated membrane potential. Mitochondrial size groups were compared for membrane potential differences. Homogenization frequency and P-188 supplementation (1 mM) were assessed for their effects on mitochondrial membrane potential and particle size, and particle counts. The rapid isolation method yielded mitochondria that retained sufficient membrane potential to be effectively inhibited by carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a disruptor of mitochondrial membrane potential. Larger mitochondria exhibited significantly higher JC-1 ratios, indicating greater membrane potential. Excessive homogenization (10 cycles) reduced membrane potential compared to 3 cycles homogenization (P = 0.026). P-188 significantly increased the JC-1 ratio from 10.26 ± 2.57 to 33.78 ± 17.78 (P = 0.023). Particle size and count analysis revealed that 10 cycles homogenization significantly increased particle count compared to 3 cycles homogenization (P = 0.0001), but was associated with smaller particle sizes (P = 0.0031). The rapid mitochondrial isolation method produced viable mitochondria, with larger mitochondria exhibiting superior membrane potential. Reducing homogenization frequency and incorporating P-188 improved mitochondrial quality and preserved particle size. These strategies offer promising strategies for optimizing MTx protocols. Further refinement of these techniques is necessary for their clinical application in MTx therapy.
format Article
id doaj-art-f39c713b17b8486cb705f81804980b73
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f39c713b17b8486cb705f81804980b732025-02-02T12:20:45ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-025-86760-yThe role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapyRyosuke Takegawa0Kei Hayashida1Atsushi Murao2Yusuke Endo3Cyrus E. Kuschner4Jacob Kazmi5Eriko Nakamura6Ping Wang7Lance B. Becker8Laboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthCenter for Immunology and Inflammation, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthCenter for Immunology and Inflammation, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthAbstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation protocols. This study aimed to assess a rapid mitochondrial isolation method, examine the relationship between mitochondrial size and membrane potential, and evaluate the potential benefits of Poloxamer 188 (P-188) in improving mitochondrial quality during the isolation process. Mitochondria were isolated from pectoral muscle biopsies of adult male Sprague–Dawley rats using an automated homogenizer. MitoTracker Deep Red (MTDR) staining and flow cytometry were used to assess mitochondrial purity, while the JC-1 assay evaluated membrane potential. Mitochondrial size groups were compared for membrane potential differences. Homogenization frequency and P-188 supplementation (1 mM) were assessed for their effects on mitochondrial membrane potential and particle size, and particle counts. The rapid isolation method yielded mitochondria that retained sufficient membrane potential to be effectively inhibited by carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a disruptor of mitochondrial membrane potential. Larger mitochondria exhibited significantly higher JC-1 ratios, indicating greater membrane potential. Excessive homogenization (10 cycles) reduced membrane potential compared to 3 cycles homogenization (P = 0.026). P-188 significantly increased the JC-1 ratio from 10.26 ± 2.57 to 33.78 ± 17.78 (P = 0.023). Particle size and count analysis revealed that 10 cycles homogenization significantly increased particle count compared to 3 cycles homogenization (P = 0.0001), but was associated with smaller particle sizes (P = 0.0031). The rapid mitochondrial isolation method produced viable mitochondria, with larger mitochondria exhibiting superior membrane potential. Reducing homogenization frequency and incorporating P-188 improved mitochondrial quality and preserved particle size. These strategies offer promising strategies for optimizing MTx protocols. Further refinement of these techniques is necessary for their clinical application in MTx therapy.https://doi.org/10.1038/s41598-025-86760-yMitochondrial transplantationMitochondrial isolationPoloxamer 188JC-1Mitochondrial membrane potential
spellingShingle Ryosuke Takegawa
Kei Hayashida
Atsushi Murao
Yusuke Endo
Cyrus E. Kuschner
Jacob Kazmi
Eriko Nakamura
Ping Wang
Lance B. Becker
The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
Scientific Reports
Mitochondrial transplantation
Mitochondrial isolation
Poloxamer 188
JC-1
Mitochondrial membrane potential
title The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
title_full The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
title_fullStr The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
title_full_unstemmed The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
title_short The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
title_sort role of homogenization cycles and poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
topic Mitochondrial transplantation
Mitochondrial isolation
Poloxamer 188
JC-1
Mitochondrial membrane potential
url https://doi.org/10.1038/s41598-025-86760-y
work_keys_str_mv AT ryosuketakegawa theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT keihayashida theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT atsushimurao theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT yusukeendo theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT cyrusekuschner theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT jacobkazmi theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT erikonakamura theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT pingwang theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT lancebbecker theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT ryosuketakegawa roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT keihayashida roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT atsushimurao roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT yusukeendo roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT cyrusekuschner roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT jacobkazmi roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT erikonakamura roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT pingwang roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy
AT lancebbecker roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy